Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
FDA Approved Drugs: Changes to Approved Drugs
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics and Pharmacogenomics: Overview
Drug Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
E David Litwack1, Elizabeth Mansfield, Jeffrey Shuren
1Food and Drug Administration, Silver Spring, MD.
No abstract available in PubMed .